Patient characteristics at baseline and weight loss in the first 3 months on a GLP-1 drug were tied to weight-loss outcomes ...

Adding online support to tirzepatide was projected to lead to greater health gains than the drug alone, assuming no extra cost, in a UK model of adults with obesity.

After a GLP-1, what works next? Among more than 20,000 patients, surgery was linked to the most weight loss, quitting cold the least, and switching from semaglutide to tirzepatide beat staying put.

Claims data miss patients who pay cash. A new survey that included these patients found out-of-pocket costs higher than $50 a month predicted GLP-1 discontinuation better than vomiting.

Given differences in training and focus, podiatrists and dermatology clinicians should establish a relationship that permits them to consult, refer, or comanage cases, advised a podiatrist.

The organization says that being forced to practice against moral beliefs and professional obligations is a significant ...

Dapagliflozin may improve ascites control in patients with cirrhosis and refractory ascites and reduce the need for ...

A review of 11 studies suggests endometriosis may take a cumulative toll on work, but long-term data are scarce.

Bulevirtide use in patients with hepatitis D-related cirrhosis is linked with less liver decompensation over 3 years, but its ...

Older adults with hoarding disorder and low income have higher a risk for functional and mild cognitive impairment, a study ...

At the recent Diabetes Technology Meeting, industry representatives shared updates on recently launched products and ...

Patients treated by female physicians in the hospital have better outcomes and reduced mortality compared with those treated ...